Immunogenicity of NVX-CoV2373 in PREVENT-19: A Phase 3, Randomized, Placebo-Controlled Trial in Adults in the United States and Mexico https://www.medrxiv.org/content/10.1101/2023.05.08.23289670
Immunogenicity of NVX-CoV2373 in PREVENT-19: A Phase 3, Randomized, Placebo-Controlled Trial in Adults in the United States and Mexico https://www.medrxiv.org/content/10.1101/2023.05.08.23289670